Antibody–drug conjugates (ADCs) are targeted immunoconjugate constructs that integrate
the potency of cytotoxic drugs with the selectivity of monoclonal antibodies, minimizing …

Microbial biofilms are becoming increasingly difficult to treat in the medical setting due to
their intrinsic resistance to antibiotics. To combat this, several biofilm dispersal agents are …

Staphylococci, like Staphylococcus aureus and S. epidermidis, are common colonizers of
the human microbiota. While being harmless in many cases, many virulence factors result in …

Increase in bacterial resistance to commonly used antibiotics is a major public health
concern generating interest in novel antibacterial treatments. Aim of this scientific endeavor …

Antimicrobial resistance (AMR) is one of the serious global public health threats that require
immediate action. With the emergence of new resistance mechanisms in infection-causing …

Biofilm has garnered a lot of interest due to concerns in various sectors such as public
health, medicine, and the pharmaceutical industry. Biofilm-producing bacteria show a …

The rise of multi-drug resistant (MDR) pathogens poses a significant challenge to the field of
infectious disease treatment. To overcome this problem, novel strategies are being explored …

Antimicrobial peptides (AMPs) are being explored as alternatives to traditional antibiotics to
combat the rising antimicrobial resistance. Insects have proven to be a valuable source of …

Mixed-species biofilm is one of the most frequently recorded clinical problems. Mixed
biofilms develop as a result of interactions between microorganisms of a single or multiple …

Bioprospecting is the discovery and exploration of biological diversity found within
organisms, genetic elements or produced compounds with prospective commercial or …